Two distinct protein-protein interfaces drive cooperative binding of the herpes simplex virus protein ICP8 to ssDNA, filament formation and annealing essential for viral replication.

两种不同的蛋白质-蛋白质界面驱动单纯疱疹病毒蛋白 ICP8 与 ssDNA 的协同结合、丝状体形成和退火,这对病毒复制至关重要

阅读:3
作者:Discipio Katherine A, Krucinska Jolanta, Szczepaniak Renata, Erlandsen Heidi, Makkay Andrea M, Wright Lee R, Wright Dennis L, Weller Sandra K
Herpes simplex virus (HSV) replicates by forming DNA concatemers using a single strand annealing mechanism mediated by the multifunctional HSV protein ICP8. ICP8 binds cooperatively to form nucleoprotein filaments on ssDNA and promotes annealing of complementary single strands. These functions are believed to be mediated by ICP8:ICP8 protein-protein interactions (PPIs) between the flexible C-terminal domain of ICP8 and the N-terminal domain of a second ICP8 monomer. We previously presented genetic evidence for an ICP8:ICP8 PPI hotspot between two hydrophobic regions and showed that it is essential for the cooperative binding of ICP8 to ssDNA, ICP8 filament formation in vitro, and viral replication. This involves interactions between F1142, N1143, and F1144 (FNF) in the C terminal disordered tail of ICP8 and the hydrophobic residues (F843 and W844) in the head region of the N-terminal domain on a second molecule of ICP8. In this article, we propose an additional second distinct PPI hotspot involving residues R922, within the body region of the N-terminal domain of ICP8, and D1087, within the C-terminal domain (CTD). Biophysical studies using thermal melting assays and microscale thermophoresis support an interaction between the ICP8-CTD and the N-terminal domain of ICP8 and show that mutations within each of these hotspots disrupt the interactions. Furthermore, we demonstrate that a construct consisting of the ICP8-CTD can antagonize the assembly of ICP8 filaments in vitro, block viral replication compartment formation and virus production, suggesting that these PPI hotspots may be useful in the development of new antiviral therapies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。